Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 453 participants.

Also called NCT03298802

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 453 participants (enrolled count) (from the registry)
Sponsor
The University of Texas Medical Branch, Galveston (from the registry)
Registry
  • NCT NCT03298802
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03298802. Randomized; triple masking; primary purpose prevention. Start 2017-11-21 (actual); primary completion 2025-04-22 (actual). Results posted on 2026-06-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Condition
Pre-Eclampsia
Condition
Gestational Hypertension
Condition
Superimposed Pre-Eclampsia
Condition
Hypertension, Pregnancy-Induced
Condition
Postpartum Pregnancy-Induced Hypertension
Condition
Postpartum Preeclampsia
Intervention (Drug)
Hydrochlorothiazide 50mg Tablet
Intervention (Drug)
Placebo Tablet
Lead sponsor
The University of Texas Medical Branch, Galveston (class: other)

Record details

Record id
cardio:ct-nct03298802
Content hash
6fa1637bb2f11c2993f88625f3e5be6f6ff3a53021497b18bf0b7ae6ae3f9348